519 related articles for article (PubMed ID: 19567679)
21. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
Wu S; Wang SQ; Zhang J; Tan XY; Liu JN
Int J Oncol; 2006 Mar; 28(3):731-6. PubMed ID: 16465379
[TBL] [Abstract][Full Text] [Related]
22. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
23. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype.
Ghosh SK; White LM; Ghosh R; Bankert RB
J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719
[TBL] [Abstract][Full Text] [Related]
24. A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.
Morris EC; Tsallios A; Bendle GM; Xue SA; Stauss HJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):7934-9. PubMed ID: 15908507
[TBL] [Abstract][Full Text] [Related]
25. Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8+CD4+ T cells: evidence from myeloma-bearing mouse model.
Freeman LM; Lam A; Petcu E; Smith R; Salajegheh A; Diamond P; Zannettino A; Evdokiou A; Luff J; Wong PF; Khalil D; Waterhouse N; Vari F; Rice AM; Catley L; Hart DN; Vuckovic S
J Immunol; 2011 Oct; 187(8):3987-96. PubMed ID: 21908738
[TBL] [Abstract][Full Text] [Related]
26. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
[TBL] [Abstract][Full Text] [Related]
27. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.
Kreiter S; Selmi A; Diken M; Koslowski M; Britten CM; Huber C; Türeci O; Sahin U
Cancer Res; 2010 Nov; 70(22):9031-40. PubMed ID: 21045153
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T cells cooperate with macrophages for specific elimination of MHC class II-negative cancer cells.
Corthay A
Adv Exp Med Biol; 2007; 590():195-208. PubMed ID: 17191387
[No Abstract] [Full Text] [Related]
29. Eradication of medullary multiple myeloma by CD4+ cytotoxic human T lymphocytes directed at a single minor histocompatibility antigen.
Spaapen RM; Groen RW; van den Oudenalder K; Guichelaar T; van Elk M; Aarts-Riemens T; Bloem AC; Storm G; Martens AC; Lokhorst HM; Mutis T
Clin Cancer Res; 2010 Nov; 16(22):5481-8. PubMed ID: 21062930
[TBL] [Abstract][Full Text] [Related]
30. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
[TBL] [Abstract][Full Text] [Related]
31. A mouse model for immunotherapy of myeloma.
Bogen B
Hematol J; 2002; 3(5):224-9. PubMed ID: 12391539
[TBL] [Abstract][Full Text] [Related]
32. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
[TBL] [Abstract][Full Text] [Related]
33. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
34. CD4
Bogen B; Fauskanger M; Haabeth OA; Tveita A
Cancer Immunol Immunother; 2019 Nov; 68(11):1865-1873. PubMed ID: 31448380
[TBL] [Abstract][Full Text] [Related]
35. Eliciting protective immune responses against murine myeloma challenge in lymphopenia mice through adoptive transfer of tumor antigen-specific lymphocytes and immunization of tumor vaccine secreting mIL-21.
Dou J; Wu Y; Wang J; Zhao F; Chu L; Liu C; Wen P; Hu W; Hu K; He XF; Gu N
Cancer Gene Ther; 2010 Oct; 17(10):675-83. PubMed ID: 20539320
[TBL] [Abstract][Full Text] [Related]
36. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Iwai Y; Ishida M; Tanaka Y; Okazaki T; Honjo T; Minato N
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12293-7. PubMed ID: 12218188
[TBL] [Abstract][Full Text] [Related]
37. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
38. In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcoma.
Rodeberg DA; Erskine C; Celis E
J Pediatr Surg; 2007 Aug; 42(8):1396-402. PubMed ID: 17706503
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display.
Tveita A; Fauskanger M; Bogen B; Haabeth OA
Oncotarget; 2016 Oct; 7(41):67175-67182. PubMed ID: 27626487
[TBL] [Abstract][Full Text] [Related]
40. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
